Josep Roma

1.3k total citations
49 papers, 900 citations indexed

About

Josep Roma is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Josep Roma has authored 49 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Neurology and 12 papers in Cancer Research. Recurrent topics in Josep Roma's work include Neuroblastoma Research and Treatments (13 papers), Sarcoma Diagnosis and Treatment (9 papers) and Muscle Physiology and Disorders (8 papers). Josep Roma is often cited by papers focused on Neuroblastoma Research and Treatments (13 papers), Sarcoma Diagnosis and Treatment (9 papers) and Muscle Physiology and Disorders (8 papers). Josep Roma collaborates with scholars based in Spain, Italy and Germany. Josep Roma's co-authors include Soledad Gallego, Joan Sánchez-de-Toledo, Manuel G. Roig, Miguel F. Segura, Aroa Soriano, Arnau Fargas, Ana Almazán-Moga, Luz Jubierre, Constantino Sábado and Francina Munell and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Blood.

In The Last Decade

Josep Roma

48 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Roma Spain 20 640 301 185 151 131 49 900
Suzanne E. Little United Kingdom 14 538 0.8× 229 0.8× 164 0.9× 138 0.9× 153 1.2× 15 847
Anke Waha Germany 19 967 1.5× 213 0.7× 85 0.5× 166 1.1× 72 0.5× 29 1.2k
Adam D. Durbin United States 18 1.1k 1.8× 374 1.2× 186 1.0× 228 1.5× 348 2.7× 38 1.6k
David Van Mater United States 14 540 0.8× 143 0.5× 152 0.8× 174 1.2× 45 0.3× 24 869
Nicolàs Samprón Spain 15 554 0.9× 361 1.2× 68 0.4× 230 1.5× 50 0.4× 47 939
Martyna Adamowicz‐Brice United Kingdom 6 485 0.8× 188 0.6× 105 0.6× 137 0.9× 209 1.6× 7 826
Domenico Trombetta Italy 12 358 0.6× 247 0.8× 209 1.1× 266 1.8× 54 0.4× 36 731
Agadha Wickremesekera New Zealand 16 329 0.5× 152 0.5× 113 0.6× 189 1.3× 106 0.8× 42 795
Swethajit Biswas United Kingdom 12 424 0.7× 249 0.8× 200 1.1× 209 1.4× 32 0.2× 22 690
Takuyu Taki Japan 17 654 1.0× 186 0.6× 124 0.7× 310 2.1× 268 2.0× 63 1.3k

Countries citing papers authored by Josep Roma

Since Specialization
Citations

This map shows the geographic impact of Josep Roma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Roma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Roma more than expected).

Fields of papers citing papers by Josep Roma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Roma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Roma. The network helps show where Josep Roma may publish in the future.

Co-authorship network of co-authors of Josep Roma

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Roma. A scholar is included among the top collaborators of Josep Roma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Roma. Josep Roma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hladun, Raquel, Gabriela Guillén, Gabriel Gallo-Oller, et al.. (2023). Targeting the Hedgehog Pathway in Rhabdomyosarcoma. Cancers. 15(3). 727–727. 4 indexed citations
3.
Pons, Guillem, Gabriel Gallo-Oller, Miguel F. Segura, et al.. (2023). Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. Cancers. 15(6). 1636–1636. 1 indexed citations
4.
Porpiglia, Ermelinda, Andrea J. De Micheli, Joana G. Marques, et al.. (2023). Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science Advances. 9(6). eade9238–eade9238. 31 indexed citations
5.
Jiménez, Carlos, Mariona Nadal‐Ribelles, Laura Devis, et al.. (2022). Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Molecular Cancer. 21(1). 175–175. 7 indexed citations
6.
Gallo-Oller, Gabriel, Guillem Pons, Miguel F. Segura, et al.. (2021). Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role. Pharmaceuticals. 14(8). 810–810. 12 indexed citations
7.
Gallo-Oller, Gabriel, Guillem Pons, Miguel F. Segura, et al.. (2021). Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. International Journal of Molecular Sciences. 22(23). 12921–12921. 6 indexed citations
8.
Pignata, Laura, Orazio Palumbo, Flavia Cerrato, et al.. (2020). Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors. Cancers. 12(11). 3411–3411. 7 indexed citations
9.
Mora, Jaume, Aroa Soriano, Gabriela Guillén, et al.. (2020). Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance. Cell Death and Disease. 11(8). 634–634. 19 indexed citations
10.
Gallo-Oller, Gabriel, Guillem Pons, Lucas Moreno, et al.. (2020). miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma. Cancer Letters. 477. 49–59. 22 indexed citations
11.
Soriano, Aroa, Olga Piskareva, Carlos Jiménez, et al.. (2019). Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma. Cellular and Molecular Life Sciences. 76(11). 2231–2243. 30 indexed citations
12.
Jiménez, Carlos, Aroa Soriano, Josep Roma, et al.. (2019). Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer. Frontiers in Oncology. 9. 1173–1173. 13 indexed citations
13.
Anvar, Zahra, et al.. (2019). Origins of DNA methylation defects in Wilms tumors. Cancer Letters. 457. 119–128. 25 indexed citations
14.
Abarrategi, Ander, Fernando González‐Camacho, Álvaro Morales‐Molina, et al.. (2018). Clonal dynamics in osteosarcoma defined by RGB marking. Nature Communications. 9(1). 3994–3994. 36 indexed citations
15.
Almazán-Moga, Ana, Pablo Velasco, Katja Simon‐Keller, et al.. (2017). Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands. British Journal of Cancer. 117(9). 1314–1325. 23 indexed citations
16.
Jubierre, Luz, Aroa Soriano, Stephan P. Tenbaum, et al.. (2016). BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways. Oncogene. 35(39). 5179–5190. 52 indexed citations
17.
Soriano, Aroa, et al.. (2015). Nuevas estrategias terapéuticas para el neuroblastoma basadas en el uso de microRNAs. Anales de Pediatría. 85(2). 109.e1–109.e6. 5 indexed citations
18.
Soriano, Aroa, Luz Jubierre, Ana Almazán-Moga, et al.. (2013). microRNAs as pharmacological targets in cancer. Pharmacological Research. 75. 3–14. 47 indexed citations
19.
Almazán-Moga, Ana, Pablo Velasco, Jaume Reventós, et al.. (2012). Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells. British Journal of Cancer. 107(8). 1374–1383. 21 indexed citations
20.
Roma, Josep, Francina Munell, Arnau Fargas, & Manuel G. Roig. (2004). Evolution of pathological changes in the gastrocnemius of the mdx mice correlate with utrophin and ?-dystroglycan expression. Acta Neuropathologica. 108(5). 443–452. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne E. Little Breakdown of academic impact, for papers by Anke Waha Breakdown of academic impact, for papers by Adam D. Durbin Breakdown of academic impact, for papers by David Van Mater Breakdown of academic impact, for papers by Nicolàs Samprón Breakdown of academic impact, for papers by Martyna Adamowicz‐Brice Breakdown of academic impact, for papers by Domenico Trombetta Breakdown of academic impact, for papers by Agadha Wickremesekera Breakdown of academic impact, for papers by Swethajit Biswas Breakdown of academic impact, for papers by Takuyu Taki
Rankless by CCL
2026